切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Hck - Insulin and Insulin-like Receptors - Ca2 /calmodulin-dependent protein kinases (CaMKs) - MET

22件产品中的 1-10

页面
每页
清除全部
  1. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM激酶II抑制剂
      ≥29.95 mg/mL
      ≥20.7 mg/mL
  2. Rottlerin
    B6803 Rottlerin
     1 Citation
    中文名: 揪毒素
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC抑制剂
      ≥23.6 mg/mL
      insoluble in H2O
  3. Autocamtide-2-related inhibitory peptide
    B6831 Autocamtide-2-related inhibitory peptide
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: 钙调蛋白依赖性蛋白激酶II(CaM激酶II,CaMKII)抑制剂
      ≥40.2 mg/mL
      ≥45.7 mg/mL
  4. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR2抑制剂
      ≥23.45 mg/mL
      insoluble in H2O
  5. KN-93 hydrochloride
    B1306 KN-93 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaMK II抑制剂
      ≥26.9 mg/mL
      ≥5.51 mg/mL
  6. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O
  7. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  8. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met(野生型/突变型)抑制剂
      ≥24.8 mg/mL
      insoluble in H2O
  9. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  10. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met抑制剂
      ≥18.47 mg/mL
      ≥2.29 mg/mL

22件产品中的 1-10

页面
每页